Description
IGF::OT::IGF FY15 RED CROSS BLOOD SERVICE
First action · last action
2014-10-01 · 2015-11-19
Transactions
3
First transaction's obligation
$250,000
Base + all options value (sum of deltas)
$130,559
Extent competed
NOT AVAILABLE FOR COMPETITION
Other than full & open authority
AUTHORIZED BY STATUTE
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$250,000= $250,000
- Mod P000012015-05-27-$75,000= $175,000
- Mod P000022015-11-19-$44,441= $130,559
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$250,000 | $250,000 | IGF::OT::IGF FY15 RED CROSS BLOOD SERVICE |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2015-05-27 | −$75,000 | $175,000 | IGF::OT::IGF FY15 RED CROSS BLOOD SERVICE |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2015-11-19 | −$44,441 | $130,559 | IGF::OT::IGF FY15 RED CROSS BLOOD SERVICE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI G69LHXJ3ABL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25226D0049 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25226N0550 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,500 | FY2026 |
| 36C25226N0551 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,100 | FY2026 |
| 36C25226N0549 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $170 | FY2026 |
| 36C25226N0548 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,000 | FY2026 |
| 36C25026P0816 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $19,329 | FY2026 |
Other recipients under Q508 from 614-MEMPHIS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24915C20298 | MID SOUTH REGIONAL BLOOD CENTER | 614-MEMPHIS | $435,542 | FY2015 |
| VA24914J0112 | SEBIA, INC. | 614-MEMPHIS | $19,410 | FY2014 |
| VA24913J0133 | CEPHEID | 614-MEMPHIS | $60,006 | FY2013 |
| VA24913C0316 | MID SOUTH REGIONAL BLOOD CENTER | 614-MEMPHIS | $642,132 | FY2013 |
| VA24912F0189 | BOSTON BASKIN CANCER GROUP, PLC. | 614-MEMPHIS | $0 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24915C20311_3600_-NONE-_-NONE- · retrieved 2026-09-27.